These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 34654347)

  • 1. Cross-talk between immune system and microbiota in COVID-19.
    Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis?
    Chaves Andrade M; Souza de Faria R; Avelino Mota Nobre S
    Med Hypotheses; 2020 Nov; 144():110206. PubMed ID: 33254513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Is there a role for immunonutrition in obese patient?
    Di Renzo L; Gualtieri P; Pivari F; Soldati L; Attinà A; Leggeri C; Cinelli G; Tarsitano MG; Caparello G; Carrano E; Merra G; Pujia AM; Danieli R; De Lorenzo A
    J Transl Med; 2020 Nov; 18(1):415. PubMed ID: 33160363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.
    Hussain I; Cher GLY; Abid MA; Abid MB
    Front Immunol; 2021; 12():765965. PubMed ID: 34721437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics in Medicine: A Long Debate.
    Stavropoulou E; Bezirtzoglou E
    Front Immunol; 2020; 11():2192. PubMed ID: 33072084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
    Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
    Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection.
    Spagnolello O; Pinacchio C; Santinelli L; Vassalini P; Innocenti GP; De Girolamo G; Fabris S; Giovanetti M; Angeletti S; Russo A; Mastroianni CM; Ciccozzi M; Ceccarelli G; d'Ettorre G
    Chemotherapy; 2021; 66(1-2):24-32. PubMed ID: 33756475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
    Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
    Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
    Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.
    Chakraborty C; Sharma AR; Bhattacharya M; Dhama K; Lee SS
    World J Gastroenterol; 2022 Jul; 28(25):2802-2822. PubMed ID: 35978881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between COVID-19 and the gut-brain axis: a gut feeling.
    Kalam N; Balasubramaniam VRMT
    Postgrad Med J; 2024 Jul; 100(1186):539-554. PubMed ID: 38493312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
    Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
    Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.